Advisory Services Network’s Amicus Therapeutics FOLD Stock Holding History

Advisory Services Network’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-119	Closed	-$1.72K	–	3063
2026 Q1	$1.72K	Buy	+119	New	+$1.71K	﹤0.01%	4177
2020 Q4	–	Sell	-634	Closed	-$13K	–	3424
2020 Q3	$9K	Buy	+634	New	+$9.24K	﹤0.01%	2486
2020 Q2	–	Sell	-599	Closed	-$6K	–	1639
2020 Q1	$6K	Hold	599	–	–	﹤0.01%	2405
2019 Q4	$6K	Buy	+599	New	+$5.48K	﹤0.01%	2550
2018 Q3	–	Sell	-87	Closed	-$1K	–	2536
2018 Q2	$1K	Hold	87	–	–	﹤0.01%	2355
2018 Q1	$1K	Hold	87	–	–	﹤0.01%	2469
2017 Q4	$1K	Hold	87	–	–	﹤0.01%	2441
2017 Q3	$1K	Buy	+87	New	+$1.15K	﹤0.01%	2264

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Advisory Services Network's FOLD Position: Q2 2026 in Review

Advisory Services Network sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 119 shares — an estimated $1.72K sold.

Advisory Services Network first reported a position in FOLD in Q3 2017 and held it in 8 quarters. The position peaked at $9K in Q3 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Advisory Services Network reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 119 Amicus Therapeutics shares in Q2 2026, an estimated $1.72K.
Advisory Services Network first reported a position in Amicus Therapeutics in Q3 2017 and held it in 8 quarters.
Advisory Services Network's Amicus Therapeutics position peaked at $9K in Q3 2020.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.